VSee Health appoints cofounder Dr. Milton Chen as board chairman

Published 20/11/2025, 15:14
VSee Health appoints cofounder Dr. Milton Chen as board chairman

SAN JOSE - VSee Health, Inc. (NASDAQ:VSEE), a telehealth technology and services company, announced Thursday the appointment of cofounder and CEO Dr. Milton Chen as Chairman of the Board. The micro-cap company, currently valued at just $10.37 million, appears undervalued according to InvestingPro analysis, despite facing significant financial challenges with a debt burden that exceeds its equity position.

Chen, who developed the first version of the VSee software while completing his PhD at Stanford University, has led the company's strategy focused on no-code, low-code AI infrastructure for healthcare.

The appointment comes as VSee positions itself as an integration solution for AI healthcare companies seeking to deploy their technologies in hospital settings. The company's platform provides EMR integration, events queueing, and security features that allow AI modules to connect with hospital digital frameworks.

"I am not smart enough to pick which AI company will be the next big winner. But just like the goldrush miners, they all need picks and shovels if they hope to strike gold. VSee is that digital 'pick and shovel' to allow all AI companies to quickly find their gold," Chen said in the press release.

Chen brings over 15 years of AI telehealth product development and board-level leadership experience to the chairman role. His work with VSee includes deployments for high-profile users including Angelina Jolie, UN Secretary General António Guterres, former UN Secretary General Ban Ki-moon, and the rock band Linkin Park.

VSee Health, which trades on the Nasdaq under the ticker VSEE, provides an API-driven platform that integrates secure video, device data, and EHR connectivity. The company holds a FedRAMP High Authority to Operate from the U.S. Department of Health and Human Services and serves clients including NASA, McKesson, DaVita, and the country of Qatar.

In other recent news, VSee Health Inc. has made significant strides with its recent FedRAMP Moderate authorization, enabling the company to secure federal government contracts for its telehealth platform. This development also supports the company's expansion into intensive care units with robotic assistance systems, allowing real-time remote monitoring by clinicians. Additionally, VSee Health has entered into a three-year agreement with a major non-profit academic health system to provide virtual urgent care and behavioral health services across over 100 facilities, with services commencing on January 1, 2026. The contract is volume-based and does not impose a revenue ceiling.

Further expanding its global footprint, VSee Health is in discussions with Philippine officials and the Philippine Tuberculosis Society to potentially enhance healthcare delivery in Naga City through digital innovation. These talks aim to address healthcare challenges such as the low prenatal check-up rates in the region. The company is exploring opportunities to implement its AI-powered telehealth platform to tackle these issues. These developments highlight VSee Health's strategic efforts to grow its telehealth services both domestically and internationally.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.